Barba, A.; López-Vilaró, L.; Ferre, M.; Martinez-Recio, S.; Majem, M.; Sullivan, I.; Salazar, J.
CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer. Int. J. Mol. Sci. 2025, 26, 4245.
https://doi.org/10.3390/ijms26094245
AMA Style
Barba A, López-Vilaró L, Ferre M, Martinez-Recio S, Majem M, Sullivan I, Salazar J.
CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer. International Journal of Molecular Sciences. 2025; 26(9):4245.
https://doi.org/10.3390/ijms26094245
Chicago/Turabian Style
Barba, Andrés, Laura López-Vilaró, Malena Ferre, Sergio Martinez-Recio, Margarita Majem, Ivana Sullivan, and Juliana Salazar.
2025. "CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer" International Journal of Molecular Sciences 26, no. 9: 4245.
https://doi.org/10.3390/ijms26094245
APA Style
Barba, A., López-Vilaró, L., Ferre, M., Martinez-Recio, S., Majem, M., Sullivan, I., & Salazar, J.
(2025). CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer. International Journal of Molecular Sciences, 26(9), 4245.
https://doi.org/10.3390/ijms26094245